SolAeroMed Inc.
$50,000.00 CAD
≈ 8 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2018-2019
- Agreement period
- February 15, 2019 – January 31, 2020
- Reference
- nrc-cnrc:172-2018-2019-Q4-924681
Published purpose
SolAeroMed Inc is developing respiratory based technologies spun out of the University of Calgary. The project will support a proof of concept study to evaluate the firm's lead drug S1226 in Cystic Fibrosis (CF).
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions